Interactions of the novel inhibitors of MAO-B Ro 19-6327 and Ro 16-6491 with the active site of the enzyme.
Cesura
A M
AM
Pharmaceutical Research Dept., F. Hoffmann La Roche & Co., Basle, Switzerland.
Imhof
R
R
Galva
M D
MD
Kettler
R
R
Da Prada
M
M
D000345:Affinity Labels; D000818:Animals; D001549:Benzamides / Q000378:metabolism* / Q000494:pharmacology; D001665:Binding Sites; D006801:Humans; D066298:In Vitro Techniques; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D010848:Picolinic Acids / Q000378:metabolism* / Q000494:pharmacology
D000345:Affinity Labels; D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids; C059303:lazabemide; C051040:Ro 16-6491; D008995:Monoamine Oxidase